Carl Domino’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$241K Sell
83,000
-6,000
-7% -$20.5K 0.29% 85
2017
Q2
$396K Hold
89,000
0.46% 64
2017
Q1
$415K Hold
89,000
0.45% 60
2016
Q4
$542K Hold
89,000
0.58% 56
2016
Q3
$473K Hold
89,000
0.45% 63
2016
Q2
$338K Hold
89,000
0.32% 71
2016
Q1
$246K Buy
89,000
+25,000
+39% +$90.5K 0.22% 97
2015
Q4
$363K Hold
64,000
0.28% 75
2015
Q3
$339K Sell
64,000
-2,900
-4% -$22.4K 0.27% 78
2015
Q2
$555K Hold
66,900
0.38% 68
2015
Q1
$309K Buy
66,900
+16,900
+34% +$55K 0.23% 95
2014
Q4
$152K Buy
+50,000
New +$148K 0.08% 164

Other funds holding SGYP

Carl Domino's SGYP Position: Q3 2017 in Review

Carl Domino reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 6.7% in Q3 2017, selling an estimated $20.5K and leaving 83,000 shares worth $241K. The position accounts for 0.29% of the portfolio, ranked #85.

Carl Domino first reported a position in SGYP in Q4 2014 and has held it in 12 quarters since. The position peaked at $555K in Q2 2015. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Carl Domino held 83,000 shares of Synergy Pharmaceuticals, Inc Common Stock worth $241K as of Q3 2017.
  • Carl Domino sold 6,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $20.5K.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.29% of Carl Domino's portfolio in Q3 2017, its #85 holding.
  • Carl Domino first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2014 and has held it in 12 quarters since.
  • Carl Domino's Synergy Pharmaceuticals, Inc Common Stock position peaked at $555K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.